mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
-0.05 |
0.3 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.3 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.3 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.3 |